231 related articles for article (PubMed ID: 4036221)
1. [Bromocriptine treatment of hyperprolactinemia].
Gauer J; Heberling HJ; Stubert B; Richardt W; Lohmann D
Z Gesamte Inn Med; 1985 Jul; 40(13):393-6. PubMed ID: 4036221
[TBL] [Abstract][Full Text] [Related]
2. Metergoline and bromocriptine in the management of tumoral and idiopathic hyperprolactinemia.
Falsetti L; Roggia A; Loda G; Turla R; Scagliola T; Schimberni M; Pontiroli AE
Horm Metab Res; 1983 Aug; 15(8):380-4. PubMed ID: 6618428
[TBL] [Abstract][Full Text] [Related]
3. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment.
Sartorio A; Pizzocaro A; Liberati D; De Nicolao G; Veldhuis JD; Faglia G
Clin Endocrinol (Oxf); 2000 Jun; 52(6):703-12. PubMed ID: 10848874
[TBL] [Abstract][Full Text] [Related]
4. [Bromocriptine therapy of prolactinoma in pregnancy].
Nehmzow M; Ventz M; Meng W
Zentralbl Gynakol; 1985; 107(14):899-903. PubMed ID: 4036407
[TBL] [Abstract][Full Text] [Related]
5. Bromocriptine for induction of ovulation in hyperprolactinemic amenorrhea.
Nillius SJ
Acta Eur Fertil; 1984; 15(2):83-91. PubMed ID: 6475464
[TBL] [Abstract][Full Text] [Related]
6. [Primary hyperprolactinemic amenorrhea. Report of 4 patients].
Rudolf K; Smid I; Kunkel S; Bazsa-Kassai Z
Zentralbl Gynakol; 1985; 107(14):894-8. PubMed ID: 3929499
[TBL] [Abstract][Full Text] [Related]
7. [An endocrinological study of hyperprolactinemia and its treatment (author's transl)].
Kimura T; Narita O; Suzuki M; Tomoda Y; Kuwayama A; Kageyama N
Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jun; 32(6):784-92. PubMed ID: 6787150
[TBL] [Abstract][Full Text] [Related]
8. [Effects of therapy and pregnancy on hyperprolactemia caused by a pituitary adenoma. A clinical case].
Pasinetti E; Schivardi MR; Falsetti L; Gastaldi A
Minerva Ginecol; 1989 Mar; 41(3):157-60. PubMed ID: 2666885
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic use of bromocriptine in women with amenorrhea-galactorrhea and suspected pituitary microadenoma.
Jewelewicz R
Adv Biochem Psychopharmacol; 1980; 23():209-15. PubMed ID: 7395612
[No Abstract] [Full Text] [Related]
10. [Effect of tamoxifen on the treatment of pituitary adenomas with bromocriptine].
Yamashita M; Hirakawa T; Tashiro Y; Matsuda T; Kibe M; Fukushima T; Tomonaga M
No Shinkei Geka; 1987 Jan; 15(1):65-72. PubMed ID: 3822068
[TBL] [Abstract][Full Text] [Related]
11. Long-term treatment of bromocriptine-intolerant prolactinoma patients with CV 205-502.
Glaser B; Nesher Y; Barziliai S
J Reprod Med; 1994 Jun; 39(6):449-54. PubMed ID: 7932398
[TBL] [Abstract][Full Text] [Related]
12. Bromocriptine treatment of microprolactinomas: evidence of stable prolactin decrease after drug withdrawal.
Moriondo P; Travaglini P; Nissim M; Conti A; Faglia G
J Clin Endocrinol Metab; 1985 Apr; 60(4):764-72. PubMed ID: 3919052
[TBL] [Abstract][Full Text] [Related]
13. Bromocriptine treatment of pituitary adenomas. Evaluation of withdrawal effect.
Coculescu M; Simionescu N; Oprescu M; Alessandrescu D
Endocrinologie; 1983; 21(3):157-68. PubMed ID: 6635518
[TBL] [Abstract][Full Text] [Related]
14. [Study on hyperprolactinemic anovulatory syndrome and treatment with bromocriptine (author's transl)].
Fukunaga T
Acta Obstet Gynaecol Jpn; 1981 Feb; 33(2):229-38. PubMed ID: 7015779
[TBL] [Abstract][Full Text] [Related]
15. [Results of treatment in the hyperprolactinemic anovulatory syndrome].
Justus B; Richter B; Seiler E; Held HJ; Köhler K; Schaps P
Zentralbl Gynakol; 1985; 107(21):1296-9. PubMed ID: 4082817
[TBL] [Abstract][Full Text] [Related]
16. [Amenorrhoea and hyperprolactinaemia (author's transl)].
Tscherne G
Wien Klin Wochenschr; 1979 Dec; 91(23):790-3. PubMed ID: 538933
[TBL] [Abstract][Full Text] [Related]
17. Serum prolactin and ovarian function after discontinuation of drug treatment for hyperprolactinaemia: a study with bromocriptine and metergoline.
Mattei AM; Ferrari C; Ragni G; Benco R; Picciotti MC; Rampini P; Caldara R; Crosignani PG
Br J Obstet Gynaecol; 1984 Mar; 91(3):244-50. PubMed ID: 6704349
[TBL] [Abstract][Full Text] [Related]
18. Rapid regression of pituitary tumours during bromocriptine treatment of women with hyperprolactinaemia.
Bergh T; Nillius SJ; Lundberg PO; Moström U; Enoksson P; Ohman L; Wide L
Ups J Med Sci; 1982; 87(3):259-67. PubMed ID: 7157557
[TBL] [Abstract][Full Text] [Related]
19. Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study.
Molitch ME; Elton RL; Blackwell RE; Caldwell B; Chang RJ; Jaffe R; Joplin G; Robbins RJ; Tyson J; Thorner MO
J Clin Endocrinol Metab; 1985 Apr; 60(4):698-705. PubMed ID: 3882737
[TBL] [Abstract][Full Text] [Related]
20. Persisting suppression of prolactin secretion after long-term treatment with bromocriptine in patients with prolactinomas.
Eversmann T; Fahlbusch R; Rjosk HK; von Werder K
Acta Endocrinol (Copenh); 1979 Nov; 92(3):413-27. PubMed ID: 574700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
